Rothmann M - Search Results

1

14th Annual University of Pennsylvania Conference on statistical issues in clinical trials/subgroup analysis in clinical trials: Opportunities and challenges (afternoon panel discussion).

Imai K, Rosenblum M, Rothmann M. Imai K, et al. Among authors: rothmann m. Clin Trials. 2023 Aug;20(4):405-415. doi: 10.1177/17407745231169681. Epub 2023 May 6. Clin Trials. 2023. PMID: 37148213 No abstract available.

2

Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek.

McShane LM, Rothmann MD, Fleming TR. McShane LM, et al. Clin Trials. 2023 Aug;20(4):341-350. doi: 10.1177/17407745231169692. Epub 2023 Apr 24. Clin Trials. 2023. PMID: 37095696 Free PMC article.

3

Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Panel discussion on considerations in design and analysis.

Rothmann M, Crown W, Louis TA, Permutt T, Ruberg S, Segal J, Scott J. Rothmann M, et al. Pharm Stat. 2021 Sep;20(5):952-964. doi: 10.1002/pst.2077. Epub 2020 Oct 28. Pharm Stat. 2021. PMID: 33118319

4

Testing in a Prespecified Subgroup and the Intent-to-Treat Population.

Rothmann MD, Zhang JJ, Lu L, Fleming TR. Rothmann MD, et al. Drug Inf J. 2012 Mar 1;46(2):175-179. doi: 10.1177/0092861512436579. Drug Inf J. 2012. PMID: 22723719 Free PMC article.

5

Retrieved-Dropout-Based multiple imputation for time-to-event data in cardiovascular outcome trials.

He J, Crackel R, Koh W, Chen LW, Li F, Zhang J, Rothmann M. He J, et al. Among authors: rothmann m. J Biopharm Stat. 2023 Mar;33(2):234-252. doi: 10.1080/10543406.2022.2118763. Epub 2022 Sep 19. J Biopharm Stat. 2023. PMID: 36121193

6

Some essential considerations in the design and conduct of non-inferiority trials.

Fleming TR, Odem-Davis K, Rothmann MD, Li Shen Y. Fleming TR, et al. Clin Trials. 2011 Aug;8(4):432-9. doi: 10.1177/1740774511410994. Clin Trials. 2011. PMID: 21835862 Free PMC article.

7

Perspectives on informative Bayesian methods in pediatrics.

Travis J, Rothmann M, Thomson A. Travis J, et al. Among authors: rothmann m. J Biopharm Stat. 2023 Nov 2;33(6):830-843. doi: 10.1080/10543406.2023.2170405. Epub 2023 Jan 29. J Biopharm Stat. 2023. PMID: 36710384

8

Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER.

Ionan AC, Clark J, Travis J, Amatya A, Scott J, Smith JP, Chattopadhyay S, Salerno MJ, Rothmann M. Ionan AC, et al. Among authors: rothmann m. Ther Innov Regul Sci. 2023 May;57(3):436-444. doi: 10.1007/s43441-022-00483-0. Epub 2022 Dec 2. Ther Innov Regul Sci. 2023. PMID: 36459346 Free PMC article. Review.

9

Resampling-based stepwise multiple testing procedures with applications to clinical trial data.

He J, Li F, Gao Y, Rothmann M. He J, et al. Among authors: rothmann m. Pharm Stat. 2021 Mar;20(2):297-313. doi: 10.1002/pst.2076. Epub 2020 Oct 25. Pharm Stat. 2021. PMID: 33103348

10

Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation.

Fleming TR, Garnett CE, Conklin LS, Corriol-Rohou S, Hariharan S, Hsu D, Mueller-Velten G, Mulugeta Y, Portman R, Rothmann MD, Stockbridge NL, Wandel S, Zhang J, Yao L. Fleming TR, et al. Ther Innov Regul Sci. 2023 Jan;57(1):109-120. doi: 10.1007/s43441-022-00445-6. Epub 2022 Sep 3. Ther Innov Regul Sci. 2023. PMID: 36057747 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page